Donovanosis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 28: Line 28:
*[[Strictures]] or [[fistulas]] of the [[urethra]], [[vagina]], or [[anus]]<ref name="VelhoSouza2008"></ref>
*[[Strictures]] or [[fistulas]] of the [[urethra]], [[vagina]], or [[anus]]<ref name="VelhoSouza2008"></ref>
*[[Coinfection]] with other [[sexually transmitted infections]] including: [[syphillis]], [[chancroid]], and [[Human Immunodeficiency Virus (HIV)]]
*[[Coinfection]] with other [[sexually transmitted infections]] including: [[syphillis]], [[chancroid]], and [[Human Immunodeficiency Virus (HIV)]]
*[[Carcinoma]]<ref name=" O'Farrell"></ref>
*[[Carcinoma]] (in 0.25% of cases)<ref name=" O'Farrell"></ref>


==Prognosis==
==Prognosis==

Revision as of 14:59, 2 March 2016

Donovanosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Donovanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Donovanosis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Donovanosis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Donovanosis natural history, complications and prognosis

CDC on Donovanosis natural history, complications and prognosis

Donovanosis natural history, complications and prognosis in the news

Blogs on Donovanosis natural history, complications and prognosis

Directions to Hospitals Treating Donovanosis

Risk calculators and risk factors for Donovanosis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]; Nate Michalak, B.A.

Overview

Natural History

  • The incubation period of Klebsiella granulomatis is debated and ranges from 1 to 360 days with a median time of 50 days.[1]
  • Donovanosis begins with a firm papule or subcutaneous nodule which eventually ulcerates.[2]
  • The ulcer slowly progresses centrifugally, without pain, to form areas of granulomatous tissue.[3]
  • Ulcers may autoinoculate creating multiple lesions.
  • "Pseudobuboes" may appear, which are nodular lesions that resemble lymphadenopathy.[4]
  • Fibrosis may occur leading to elephantiasis-like swelling as a result of chronic ulcers.
  • K. granulomatis may disseminate causing extragenital lesions in the following areas:[4]
  • mouth
  • cheek
  • neck
  • pharynx
  • larynx
  • nose
  • thorax
  • K. granulomatis may also disseminate to the abdomen, intestines, liver, lungs, uterus, and ovaries causing systemic infection.[3]

Complications

Prognosis

  • Treating this disease early decreases the chances of tissue damage or scarring. Untreated disease leads to damage of the genital tissue.
  • Donovanosis may reoccur after 6 to 18 months.

References

  1. Greenblatt, R. B.; Dienst, R. B.; Pund, E. R.; Torpin, Richard (1939). "EXPERIMENTAL AND CLINICAL GRANULOMA INGUINALE". Journal of the American Medical Association. 113 (12): 1109. doi:10.1001/jama.1939.02800370025006. ISSN 0002-9955.
  2. 2.0 2.1 O'Farrell N (2002). "Donovanosis". Sex Transm Infect. 78 (6): 452–7. PMC 1758360. PMID 12473810.
  3. 3.0 3.1 3.2 Velho, Paulo Eduardo Neves Ferreira; Souza, Elemir Macedo de; Belda Junior, Walter (2008). "Donovanosis". Brazilian Journal of Infectious Diseases. 12 (6). doi:10.1590/S1413-86702008000600015. ISSN 1413-8670.
  4. 4.0 4.1 4.2 Richens J (1991). "The diagnosis and treatment of donovanosis (granuloma inguinale)". Genitourin Med. 67 (6): 441–52. PMC 1194766. PMID 1774048.

Template:WikiDoc Sources